![beckman coulter diagnostics beckman coulter diagnostics](https://i.ytimg.com/vi/TpLgpL57jUE/hqdefault.jpg)
BECKMAN COULTER DIAGNOSTICS MANUAL
With the DxA 5000 Fit, mid-sized labs can enjoy the same benefits as larger-volume labs:Ĭomprehensive workflow automation to reduce up to 80% of manual steps through pre-analytical, analytical and post-analytical automation ix, conserving precious human resources to do higher-value clinical work It has a flexible design which is important in a lab like ours where space is a precious commodity and reduces our manual process steps by up to 80%, helping us meet today's unprecedented need for COVID-19 and routine tests." "Beckman Coulter's DxA 5000 Fit solution is the right fit for us. However, for medium-volume labs like ours that process fewer than 4,000 tests per day, comprehensive workflow-automation solutions haven't been an option," said Susan Enciso, System Supervisor of Chemistry, Excela Health. "For large laboratories, TLA is a reality today. Automation plays a key role in helping to address many of these issues while enabling precious resources to focus on high-value, clinical tasks – this has proven particularly true during the COVID-19 pandemic viii. The results found that staffing (26 percent) and turnaround time (23 percent) were identified as top priorities vii. In a survey, lab directors and managers were asked to identify the key challenges hospital labs are facing. From its compact footprint and minimizing manual work by 80%, to intelligent routing that makes sure our acute patients get their results faster than routine ones, the DxA 5000 Fit was just the right fit for us." What we needed was a compact automation system that reduced the number of steps, requiring minimum human intervention and generated a valid result at first pass so that our lab professionals are not moving samples around but performing the valuable scientific tasks they are trained for. "At the Harrogate District Hospital site, we knew that a large automated system will be too large and excessive and a standalone system doesn't give us the streamlined workflow we want. "When we look at automation for our labs it's a balancing act between system throughput capacity, test menu and footprint of the system," said Afruj Ruf, managing director at Integrated Pathology Solutions LLP, Airedale NHS Foundation Trust.
![beckman coulter diagnostics beckman coulter diagnostics](https://media.beckman.com/-/media/corporate/contact-us/indianapolis-office-image.jpg)
However, the TLA solutions that cater to labs processing high-sample volumes are out of reach for smaller volume labs due to space requirements and infrastructure constraints. Labs of all sizes are facing the same challenges: shortage of laboratory technologists and technicians iv, historic financial pressures on hospitals and health systems v, and physically and mentally exhausted laboratory professionals vi – a pre-pandemic problem that has since been exacerbated. This means that testing-volume pressure on labs is going to continue.
![beckman coulter diagnostics beckman coulter diagnostics](https://media.beckmancoulter.com/-/media/diagnostics/products/immunoassay/unicel-dxi-800/images/immun-unicel-dxi-800-web.jpg)
Despite vaccines, many industry players suggest SARS-CoV-2 testing volumes won't be impacted in the near term, and the demand for COVID-19-related testing will continue through 2021 and potentially into 2022 iii. adults delayed or avoided medical care ii. i According to the CDC, an estimated 41% of U.S.
BECKMAN COULTER DIAGNOSTICS TRIAL
The clinical laboratory has gone through trial by fire in 2020, where total testing was 245% of baseline volumes, with ~55% being SARS-CoV-2 molecular tests.